Skripsi
OPTIMASI FORMULA DAN KARAKTERISASI SOLID SELF NANO-EMULSIFYING DRUG DELIVERY SYSTEM CEFIXIME MENGGUNAKAN AEROSIL®-200 DAN MG STEARAT DENGAN DESAIN D-OPTIMAL
Cefixime is a BCS class IV antibiotic characterized by low solubility and permeability, resulting in limited oral bioavailability. The L-SNEDDS system can improve drug solubility; however, it has limitations in liquid form, leading to the development of solid self-nanoemulsifying drug delivery system (S-SNEDDS). This study aimed to optimize cefixime-loaded S-SNEDDS using an adsorption method with Aerosil®-200 and magnesium stearate. Optimization was performed using a D-optimal desain by varying the ratio of Aerosil®-200:magnesium stearate and L-SNEDDS:solid adsorbent. The optimum formulation was obtained at a ratio of 2:1 and 1:2, respectively, with a desirability value of 0.875, and showed good granule characteristics. Morphological characterization showed no phase separation or oil globule formation, indicating successful adsorption of the system. Dissolution studies demonstrated that S-SNEDDS significantly enhanced cefixime release, particularly in simulated intestinal fluid (SIF) pH 7.4 compared to simulated gastric fluid (SGF) and pure cefixime. The dissolution efficiency (DE₆₀) values were 88.07 ± 0.3472%, 65.24 ± 0.2363%, 15.55 ± 0.0192%, and 8.21 ± 0.0078%, respectively, with the release mechanism following the Korsmeyer-Peppas model. Diffusion studies showed that the amount of drug diffused at 180 minutes was 12.52, which was higher than that of pure cefixime (5.81). Compartmental analysis indicated that the diffusion process was better described by a three-compartment model (K3), suggesting a more complex diffusion mechanism. X-ray diffraction (XRD) analysis showed a decrease in the crystalline peak intensity of cefixime in the S-SNEDDS formulation, indicating a transition toward a more amorphous form. FTIR analysis confirmed the absence of chemical interaction between components. In conclusion, the optimized S-SNEDDS formulation of cefixime improved drug dissolution and diffusion, indicating its potential to enhance oral bioavailability.
No other version available